Could cause temporary or reversible harm; serious harm is unlikely.
Failed Impurities/Degradation Specifications: Out of specifications result observed in the drug substance for impurity test during 3-month long term stability study.
| Brand name | LEVOTHYROXINE SODIUM |
| Generic name | LEVOTHYROXINE SODIUM |
| Active ingredient(s) | LEVOTHYROXINE SODIUM |
| Distributed by / for | Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 United States |
| NDC | 68180-967-03 |
| Full product label | Levothyroxine Sodium Tablets, Lupin, 75 mcg (0.075mg), 1000 Tablets, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 United States, Manufactured by: Lupin Limited, Pithampur (M.P)- 454 775 INDIA, NDC# 68180-967-03 |
| Recalling firm | Lupin Pharmaceuticals Inc. |
| Distribution | One US distributor in Ohio. |
| Quantity | 480 1000-count bottles |
| Recall initiated | 2024-12-20 |
| Report date | 2025-01-08 |
| Recall completed | 2026-02-17 |
| Recall number | D-0167-2025 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Baltimore MD United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗